CancerVax Corp.
Allogeneic; whole-cell vaccine that expresses more than 20 antigens
To continue reading subscribe now to BioWorld Phase III Report
Learn More about BioWorld Phase III Report
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.